| Announce Date | 10/23/2025 |
| EPS Normalized Actual | $3.39 (Beat by $0.01) |
| EPS GAAP Actual | $3.39 (Beat by $0.01) |
| Revenue Actual | $1.45113B |
| Revenue Surprise | Beat by $1451.13M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $2.07 |
| EPS GAAP Estimate | $2.07 |
| Revenue Estimate | $1.226B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 12.65 | 21.04 | 12.54352 | 12.76264 | 7 |
| Dec 2027 | 14.501 | 18.35 | 14.31726 | 14.62807 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.38 | -3.054 | 1.45113B | 1.26% | -550.65M |
| FQ2 2025 (Jun 2025) | 5.21 | -1.5719 | 1.78453B | 0.83% | -256.09M |
| FQ1 2025 (Mar 2025) | 1.42 | 1.42 | 1.07153B | -4.6% | 1071.53M |
| FQ4 2024 (Dec 2024) | 0.99 | 0.99 | 0.987479B | -1.58% | 987.48M |
| FQ3 2024 (Sep 2024) | 3.3 | 3.3 | 1.43288B | -2.9% | 1432.88M |
| FQ2 2024 (Jun 2024) | 5.05 | 5.05 | 1.76978B | -4.95% | 1769.78M |
| FQ1 2024 (Mar 2024) | 2.05 | 2.05 | 1.12081B | -7.67% | 1120.81M |
| FQ4 2023 (Dec 2023) | 1.33 | 1.33 | 1.00305B | -9.26% | 1003.05M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
2.07
Consensus Revenue Estimates
1.226B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.23 | -- | 1.22266 | 1.23976 | 7 |
| FQ3 2027 (Sep 2027) | 4.77 | -- | 4.58535 | 4.92109 | 2 |
| FQ2 2027 (Jun 2027) | 6.17 | -- | 5.93115 | 6.36544 | 2 |
| FQ1 2027 (Mar 2027) | 1.91 | -- | 1.85036 | 1.96495 | 2 |
| FQ4 2026 (Oct 2026) | 3.67 | -- | 3.67 | 3.67 | 3 |
| FQ3 2026 (Jul 2026) | 5.93 | 43 | 5.93 | 5.93 | 4 |
| FQ2 2026 (Jun 2026) | 5.74 | 9.23 | 5.57287 | 6.07496 | 3 |
| FQ1 2026 (Mar 2026) | 2.07 | 31.4 | 2.00973 | 2.19079 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.08B | -- | 1.07B | 1.08B | 5 |
| FQ3 2027 (Sep 2027) | 1.72B | -- | 1.67B | 1.76B | 4 |
| FQ2 2027 (Jun 2027) | 1.97B | -- | 1.91B | 2.02B | 6 |
| FQ1 2027 (Mar 2027) | 1.21B | -- | 1.18B | 1.24B | 4 |
| FQ4 2026 (Oct 2026) | 1.51B | -- | 1.51B | 1.51B | 4 |
| FQ3 2026 (Jul 2026) | 1.9B | 23.75 | 1.9B | 1.9B | 6 |
| FQ2 2026 (Jun 2026) | 1.94B | 7.82 | 1.89B | 2.02B | 5 |
| FQ1 2026 (Mar 2026) | 1.23B | 12.6 | 1.2B | 1.28B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 6.434 | 3.38 | -3.054 | -90.36% |
| FQ2 2025 (Jun 2025) | 6.7819 | 5.21 | -1.5719 | -30.17% |
| FQ1 2025 (Mar 2025) | 1.42 | 1.42 | 100% | |
| FQ4 2024 (Dec 2024) | 0.99 | 0.99 | 100% | |
| FQ3 2024 (Sep 2024) | 3.3 | 3.3 | 100% | |
| FQ2 2024 (Jun 2024) | 5.05 | 5.05 | 100% | |
| FQ1 2024 (Mar 2024) | 2.05 | 2.05 | 100% | |
| FQ4 2023 (Dec 2023) | 1.33 | 1.33 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $2B | $1.45B | $-550.65M | -37.95% |
| FQ2 2025 (Jun 2025) | $2.04B | $1.78B | $-256.09M | -14.35% |
| FQ1 2025 (Mar 2025) | $0B | $1.07B | $1071.53M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.99B | $987.48M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.43B | $1432.88M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.77B | $1769.78M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.12B | $1120.81M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1B | $1003.05M | 100% |